Factor VIII inhibitors in mild and moderate-severity haemophilia A

Haemophilia

Volumn 4, Issue 4, 1998, Pages 558-563

  Hay, C R M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Genotype; Inhibitors; Mild haemophilia

Indexed keywords

BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; DESMOPRESSIN;

BLEEDING; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; CROSS REACTION; DISEASE SEVERITY; FAMILY HISTORY; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GENOTYPE; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; SOFT TISSUE; UROGENITAL TRACT DISEASE;

EID: 0031856491     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440558.x     Document Type: Conference Paper

References (32)

1. Lusher JM, Arkin S, Abildgaard CF, Schwarz RS. Recombinant factor VIII for the treatment of previously untreated patients with haemophilia A. N Eng J Med 1993; 328: 453-9.
2. Ehrenforth S, Kreutz W, Scharrer I, Linde R, Funk M, Gungor T. Incidence of development of factor VIII and IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-8.
3. Addiego J, Kasper CK, Abildgaard C, Hilgartner M, Lusher J, Glader B, Aledort L. Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet 1993; 342: 462-4.
4. Schwaab R, Brackmann HH, Meyer C, Seehafer J, Kirchgesser M, Hack A, et al. Haemophilia A: Mutation type determines risk of inhibitor formation. Thromb Haemost 1995; 74(6): 1402-6.
5. Sultan Y, and the French Hemophilia Study Group. Prevalence of inhibitors in a population of 3435 hemophilia patients in France. Thromb Haemost 1992; 67: 600-2.
6. Rizza CR, Spooner RGD. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom. Br Med J 1983; 286: 929-32.
7. Beck P, Giddings JC, Bloom AL. Inhibitor of factor VIII in mild haemophilia. Br J Haematol 1969; 17: 283-8.
8. Strauss HS. Acquired circulating anticoagulants in hemophilia A. N Eng J Med 1969; 281: 866-73.
9. Crowell EB. A factor VIII inhibitor in a mild hemophiliac. Am J Med Sci 1970; 260: 261-3.
10. Robboy SJ, Lewis EJ, Schun PH, Colman RW. Circulating anticoagulants to factor VIII. Am J Med 1970; 49: 742-52.
11. Lechner K, Ludwig E, Niesner H, Thaler E. Factor VIII inhibitor in a patient with mild hemophilia A. Haemostasis 1970; 1: 261-70.
12. Shapiro SS, Hultin M. Acquired inhibitors to blood coagulation factors. Sem Thromb Haemost 1975; 1: 336-85.
13. Lowe GDO, Harvie A, Forbes CD, Prentice CRM. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor. Br Med J 1976; 2: 1110-1.
14. Kesteven PJ, Holland LJ, Lawrie AS, Savidge GF. Inhibitor to factor VIII in mild haemophilia. Thromb Haemost 1984; 52(1): 50-2.
15. Bovill EG, Burns SL, Golden EA. Factor VIII antibody in a patient with mild haemophilia. Br J Haematol 1985; 61: 323-8.
16. Capel P, Toppet M, Van Remoortel E, Fondue P. Factor VIII inhibitor in mild haemophilia (letter). Br J Haematol 1986; 62: 786-7.
17. Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterisation and response to factor VIII and desmopressin. Thromb Haemost 1995; 74(2): 619-21.
18. Hay CRM, Ludlam CA, Colvin BT, Hill FGH, Preston FE, et al. on behalf of the UK Haemophilia Centre Directors Organisation Inhibitor Working Party. Factor VIII inhibitors in mild and moderate severity haemophilia A. Thromb Haemo 1998, 79(3), in press.
19. Tuddenham EGD, Schwaab R, Seehafer J, Millar DS, Gitcher J, Higuchi M, et al. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res 1994; 22: 3511-33.
20. Schwaab R, Oldenburg J, Tuddenham EGD, Brackmann HH, Olek K. Mutations in haemophilia A. Br J Haematol 1993; 83: 450-5.
21. Schwaab R, Oldenburg J, Schwaab U, Johnson DJD, Schmidt W, Olek K, et al. Characterisation of mutations within factor VIII gene of 73 unrelated mild and moderate haemophiliacs. Br J Haematol 1995, 90: 442-7.
22. 593 to Cys Mutation. Blood 1997; 90: 1902-10.
23. 593-Cys is related to antibody formation in a patient with mild haemophilia A. Blood 1997; 89: 4371-7.
24. Scandella D, Gilbert GE, Shima M, Eagleson C, Felch M, Prescott R, et al. Some factor VIII inhibitor antibodies recognise a common epitope corresponding to C2 domain amino acids 2248-2312 which overlap a phopholipid binding site. Blood 1995; 86: 1811-7.
25. Prescot R, Nakai H, Saenko EL, Scharrer I, Nilsson IM, Humphries JE, et al. The inhibitor antibody response is more complex in haemophilia A patients than in most non-hemophiliacs with factor VIII autoantibodies. Blood 1997; 89: 3663-71.
26. Cibotti R, Kanellopous JM, Cabaniols J-P, Halle-Paneko O, Kosmatopoulos K, Sercarz E, Kourilsky P. Tolerance to a self-protein involves its immunodominant involves its immunodominant but does not involve its sub-dominant determinants. Proc Natl Acad Sci USA 1992; 89: 416-24.
27. Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with haemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide and factor VIII. N Eng J Med 1988; 318: 947-50.
28. Mauser-Bunschoten EP, Niewenhuis HK, Roosendaal G, van den Berg HM. Low-dose immune tolerance induction in hemophilia A patients with inhibitors. Blood 1995; 86: 983-8.
29. Brackmann HH, Oldenberg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitors - twenty years of the "Bonn Protocol". Vox Sang 1996; 70 (Suppl 1): 30-5.
30. Naylor JA, Green PM, Montandon AJ, Rozza CR, Giannelli F. Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene. Lancet 1991; 337: 635-9.
31. Pienman WC, Deutz-Terlouw PP, Reitsma PH, Briet E. Screening for mutations in haemophilia A patients by mutiplex PCR-SSCP, southern blotting and RNA analysis; detection of a genetic abnormality in the factor VIII gene in 30 out of 35 patients. Br J Haematol 1995; 90: 442-9.
32. Bidichandani SI, Lanyon WG, Shiach CR, Lowe GDO, Connor JM. Detection of mutations in ectopic factor VIII transcripts from nine haemophilia patients and the correlation with phenotype. Hum Genet 1995; 95: 531-8.